my experience with semaglutide JOURNEY RECAP // How I lost 30 lbs in 3 months, milestones, challenges + sustainability eating too much on semaglutide

Careful glucose monitoring during transition periods helps prevent both hyperglycemia and hypoglycemia

Start with a simple 10-minute call

As these medications become among the most widely prescribed in the world, the ability to tailor treatment based on genetic profile or to target specific clinical outcomes such as cardiovascular risk reduction could transform prescribing practices well beyond their current primary use in obesity and diabetes management Sources New 23andMe Research Institute Study Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects 23andME April 8, 2026 Genetic variations linked to weight loss, side effects from GLP-1 drugs Reuters April 10, 2026

But the potential is very exciting